CHG-2021-0168
Formulation Change for Pancrelipaze-R. Container Closure Change for Pancrelipaze-R — critical change. Impacts 3 markets and 2 variations.
Change Number
CHG-2021-0168
Type
Formulation Change
Product
Status
Submitted
Owner
Dmitri Volkov
Initiated
2022-04-08
Description
Container Closure Change for Pancrelipaze-R — critical change
Impacted Markets (3)
IT — ItalyTR — TurkeyDK — Denmark
Impacted Modules
3.2.P.3
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|